NLRP3 mediates osteolysis through inflammation‐dependent and ‐independent mechanisms
Chao Qu(Xi'an University of Science and Technology), Gabriel Mbalaviele(Washington University in St. Louis), Carla A. Peña(La Jolla Institute for Immunology), Lori Broderick(Rady Children's Hospital-San Diego), Yousef Abu‐Amer(Washington University in St. Louis), Roberto Civitelli(Washington University in St. Louis), Deborah V. Novack(Washington University in St. Louis), Susan K. Grimston(Washington University in St. Louis), Jacqueline Kading(Washington University in St. Louis), Cynthia L. Hickman‐Brecks(Washington University in St. Louis), Chang Yang(Washington University in St. Louis), Samer Abu‐Amer(Washington University in St. Louis), Sheri L. Bonar(Washington University in St. Louis), Matthew D. McGeough(University of California San Diego), Hal M. Hoffman(Rady Children's Hospital-San Diego)
Cited by 73
Related Papers
Aseptic loosening of total joint replacements: mechanisms underlying osteolysis and potential therapies
|Arthritis Research & Therapy|2007|526
Tumor Necrosis Factor-α (TNF) Stimulates RANKL-induced Osteoclastogenesis via Coupling of TNF Type 1 Receptor and RANK Signaling Pathways
|Journal of Biological Chemistry|2001|499
LDHA-mediated ROS generation in chondrocytes is a potential therapeutic target for osteoarthritis
|Nature Communications|2020|386